Evidence map›Paper›PMID 18235997›Full record

ArticleAmino acids2008

Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin.

X-L Guo, L Li, D-Q Wei, Y-S Zhu, K-C Chou

Abstract read
In one paragraph

Article in Amino acids, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Insights into Omicron's Low Fusogenicity throughBioinformatics and biology insights · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Analyses of Merging Clinical and Viral Genetic Data for Influenza Surveillance.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Trends in global warming and evolution of matrix protein 2 family from influenza A virus.Interdisciplinary sciences, computational life sciences · 2009
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

X-L GuoCollege of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
L Li
D-Q Wei
Y-S Zhu
K-C Chou

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cleavage property of hemagglutinin (HA) by different proteases was the prime determinant for influenza A virus pathogenicity. In order to understand the cleavage mechanism, molecular modeling tools were utilized to study the coupled model systems of the proteases, i.e., trypsin and furin and peptides of the cleavage sites specific to H5N1 and H1 HAs, which constitute models of HA precursor in complex with cleavage proteases. The peptide segments 'RERRRKKR downward arrow G' and 'SIQSR downward arrow G' from the high pathogenic H5N1 H5 and the low pathogenic H1N1 H1 cleavage sites were docking to the trypsin and furin active pockets, respectively. It was observed through the docking studies that trypsin was able to recognize and cleave both the high pathogenic and low pathogenic hemagglutinin, while furin could only cleave the high pathogenic hemagglutinin. An analysis of binding energies indicated that furin got most of its selectivity due to the interactions with P(1), P(4), and P(6), while having less interaction with P(2) and little interactions with P(3), P(5), P(7), and P(8). Some mutations of H5N1 H5 cleavage sequence fitted less well into furin and would reduce high pathogenicity of the virus. These findings hint that we should focus at the subsites P(1), P(4), and P(6) for developing drugs against H5N1 viruses.

Indexed as

Computer SimulationFurinHemagglutininsInfluenza A Virus, H5N1 SubtypeModels, MolecularMonte Carlo MethodSoftwareTrypsinFurinHemagglutininsTrypsin

Identifiers

PMID18235997
PMCPMC7088033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.